Endometriosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman of any age
- You are currently pregnant or have been recently pregnant
- You agree to take part in the study
- You give permission for your doctor(s) or healthcare provider(s) to share your health information with the registry
- (Group 1 only) You received at least one dose of a medicine containing relugolix at any point during your pregnancy
- (Group 2 only) You have been diagnosed with a condition that relugolix is sometimes prescribed for, but you did not take any relugolix-containing medicine during your pregnancy
Who may not be able to join:
- Your pregnancy has already ended before you first make contact with the study team (you may still be enrolled but your data would be analysed separately)
- You were exposed during pregnancy to medicines known to cause birth defects, or to experimental/investigational medicines (your data would be analysed separately)
- You are unable to be contacted for follow-up during the study (your data would be analysed separately)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 650-278-8743
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Major Congenital Malformation (MCM)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.